Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG20035)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
hsa-miR-375-3p
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Cystine/glutamate transporter (SLC7A11) [Driver; Suppressor]
In total 3 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Gastric cancer | ICD-11: 2B72 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell stemness | |||||
In Vitro Model |
SGC-7901 cells | Gastric carcinoma | Homo sapiens | CVCL_0520 | |
BGC-823 cells | Gastric carcinoma | Homo sapiens | CVCL_3360 | ||
GES-1 cells | Normal | Homo sapiens | CVCL_EQ22 | ||
In Vivo Model |
Four- to eight-week-old female BALB/c nude mice were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). For the tumor-limiting dilution assay, 1 x 107, 5 x 106, and 2.5 x 106 of LV3-miR-375 cells, LV3-SLC7A11 cells, LV3-shSLC7A11 cells, LV3-miR-375-SLC7A11 cells, and LV3-NC cells (BGC-823 and SGC-7901) were subcutaneously implanted into the underarm of mice. Fifteen days later, all mice were euthanized and tumor tissues were collected and weighed. For metastasis experiment, mouse models were established by intravenous injection of cells. Three mice per group were injected with 2 x 106 cells in 200 uL RPMI-1640 serum-free media. Six weeks after injection, mice were sacrificed for collecting lung tissues.
Click to Show/Hide
|
||||
Response regulation | MiR-375 reduced the stemness of gastric cancer cells in vitro and in vivo. Mechanistically, SLC7A11 was identified as a direct target of miR-375 and miR-375 attenuated the stemness of GC cells mainly through triggering SLC7A11-dependent ferroptosis. | ||||
Experiment 2 Reporting the Ferroptosis Target of This Regulator | [2] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Gastric cancer | ICD-11: 2B72 | |||
Pathway Response | Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
MKN45 cells | Gastric adenocarcinoma | Homo sapiens | CVCL_0434 | |
AGS cells | Gastric adenocarcinoma | Homo sapiens | CVCL_0139 | ||
Hs746T cells | Gastric adenocarcinoma | Homo sapiens | CVCL_0333 | ||
NCI-N87 cells | Gastric tubular adenocarcinoma | Homo sapiens | CVCL_1603 | ||
HGC-27 cells | Gastric carcinoma | Homo sapiens | CVCL_1279 | ||
Response regulation | circRPPH1 promoted the stemness of gastric cancer cells dependent on the miR-375/SLC7A11. This study provides a potential target for gastric cancer progression based on the circRPPH1/miR-375/SLC7A11 regulatory axis. | ||||
Experiment 3 Reporting the Ferroptosis Target of This Regulator | [3] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Cervical cancer | ICD-11: 2C77 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
In Vitro Model |
Ca Ski cells | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
HeLa cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | ||
hCECs (Human cervical epithelial cells) | |||||
In Vivo Model |
The 4-week-old female BALB/c nude mice were used for constructing xenograft model. HeLa cells (1 x 107 cells/mL) were injected into the dorsal flanksusing using 1-mL syringes. Then tumor size was measured and mice received intertumoral injection of si-crEPSTI1-1 (40 uL siRNA1 for cicrEPSTI1) and negative control (40 uL negative control) every four days, respectively (5 mice/group). After 28 days, the mice were sacrificed and xenografts were measured.
Click to Show/Hide
|
||||
Response regulation | CircEPSTI1 sponges miR-375, miR-409-3p and miR-515-5p to upregulate SLC7A11 expression. CircEPSTI1- miR-375/409-3P/515-5p-SLC7A11 axis affected the proliferation of cervical cancer via the competing endogenous RNAs (ceRNA) mechanism and was relative to ferroptosis. | ||||
Gastric cancer [ICD-11: 2B72]
In total 2 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | hsa-miR-375-3p (miRNA) | miRNA | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell stemness | |||||
In Vitro Model |
SGC-7901 cells | Gastric carcinoma | Homo sapiens | CVCL_0520 | |
BGC-823 cells | Gastric carcinoma | Homo sapiens | CVCL_3360 | ||
GES-1 cells | Normal | Homo sapiens | CVCL_EQ22 | ||
In Vivo Model |
Four- to eight-week-old female BALB/c nude mice were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). For the tumor-limiting dilution assay, 1 x 107, 5 x 106, and 2.5 x 106 of LV3-miR-375 cells, LV3-SLC7A11 cells, LV3-shSLC7A11 cells, LV3-miR-375-SLC7A11 cells, and LV3-NC cells (BGC-823 and SGC-7901) were subcutaneously implanted into the underarm of mice. Fifteen days later, all mice were euthanized and tumor tissues were collected and weighed. For metastasis experiment, mouse models were established by intravenous injection of cells. Three mice per group were injected with 2 x 106 cells in 200 uL RPMI-1640 serum-free media. Six weeks after injection, mice were sacrificed for collecting lung tissues.
Click to Show/Hide
|
||||
Response regulation | MiR-375 reduced the stemness of gastric cancer cells in vitro and in vivo. Mechanistically, SLC7A11 was identified as a direct target of miR-375 and miR-375 attenuated the stemness of GC cells mainly through triggering SLC7A11-dependent ferroptosis. | ||||
Experiment 2 Reporting the Ferroptosis-centered Disease Response | [2] | ||||
Target Regulator | hsa-miR-375-3p (miRNA) | miRNA | |||
Pathway Response | Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
MKN45 cells | Gastric adenocarcinoma | Homo sapiens | CVCL_0434 | |
AGS cells | Gastric adenocarcinoma | Homo sapiens | CVCL_0139 | ||
Hs746T cells | Gastric adenocarcinoma | Homo sapiens | CVCL_0333 | ||
NCI-N87 cells | Gastric tubular adenocarcinoma | Homo sapiens | CVCL_1603 | ||
HGC-27 cells | Gastric carcinoma | Homo sapiens | CVCL_1279 | ||
Response regulation | circRPPH1 promoted the stemness of gastric cancer cells dependent on the miR-375/SLC7A11. This study provides a potential target for gastric cancer progression based on the circRPPH1/miR-375/SLC7A11 regulatory axis. | ||||
Cervical cancer [ICD-11: 2C77]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [3] | ||||
Target Regulator | hsa-miR-375-3p (miRNA) | miRNA | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
In Vitro Model |
Ca Ski cells | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
HeLa cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | ||
hCECs (Human cervical epithelial cells) | |||||
In Vivo Model |
The 4-week-old female BALB/c nude mice were used for constructing xenograft model. HeLa cells (1 x 107 cells/mL) were injected into the dorsal flanksusing using 1-mL syringes. Then tumor size was measured and mice received intertumoral injection of si-crEPSTI1-1 (40 uL siRNA1 for cicrEPSTI1) and negative control (40 uL negative control) every four days, respectively (5 mice/group). After 28 days, the mice were sacrificed and xenografts were measured.
Click to Show/Hide
|
||||
Response regulation | CircEPSTI1 sponges miR-375, miR-409-3p and miR-515-5p to upregulate SLC7A11 expression. CircEPSTI1- miR-375/409-3P/515-5p-SLC7A11 axis affected the proliferation of cervical cancer via the competing endogenous RNAs (ceRNA) mechanism and was relative to ferroptosis. | ||||
References